ESC 365 - Aspirin in patients with diabetes: primary prevention, secondary prevention or both?

ESC Premium Access

Aspirin in patients with diabetes: primary prevention, secondary prevention or both?

Session: Translating data to practice: aspirin in high-risk patient subgroups

Topic: Prevention

Speaker: Professor U. Laufs (Leipzig, DE) Professor F. Andreotti (Rome, IT)

Sponsored by Bayer AG

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speakers

Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

40 presentations

2 followers

Professor Felicita Andreotti

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

28 presentations

8 followers

4 more presentations in this session

Welcome and introduction

Speaker: Professor P. Henry (Paris, FR)

Summary

Speaker: Professor P. Henry (Paris, FR)

Looking beyond patient age: the role of aspirin in cardiovascular risk management

Speaker: Professor F. Andreotti (Rome, IT) Professor U. Laufs (Leipzig, DE)

Closing remarks

Speaker: Professor M. Gaziano

Access the full session

Translating data to practice: aspirin in high-risk patient subgroups

Speakers: Professor U. Laufs, Professor F. Andreotti, Professor P. Henry, Professor P. Henry, Professor F. Andreotti...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources